Targeting heme degradation pathway augments prostate cancer cell sensitivity to docetaxel-induced apoptosis and attenuates migrationRamia J. Salloom(University of Nebraska Medical Center), Maher Y. Abdalla(Federal Medical Centre)Frontiers in OncologyJuly 18, 202410.3389/fonc.2024.1431362Cited by 5SaveCiteExport RISWatch citationsRelated PapersHeme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma|Cancers|2021|43